NCT00270127View on ClinicalTrials.gov

Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

August 31, 1996

Study Completion Date

September 30, 1998

Conditions
AnemiaCancerNeoplasm
Interventions
DRUG

Epoetin alfa

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00270127 - Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy | Biotech Hunter | Biotech Hunter